1Barka T, van der Noen H. Expression of the eysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations [J].J Histochem Cytochem, 1993,41(12) :1863-1867.
2Filler G, Bokenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR-history, indications, and future research[J]. Clin Biochem,2005,38(1) : 1-8.
3Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009,204 (1) : 298-303.
4Ix JH,Shlipak MG,Chertow GM,et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease., data from the Heart and Soul Study[J].Circulation, 2007,115 (2) : 173- 179.
5Derzhko R;Plaksej R,Przewlocka-Kosmala M,et al. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction-contribution of cystatin C assessment[J].Coron Artery Dis,2009,20(7):453-461.
6Kilic T, Oner G, Ural E, et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome [J]. Atherosclerosis, 2009,207 (2) : 552-558.
7Garcia Acuna JM, Gonzalez-Babarro E, Grigorian Shamagian L, et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome[J]. Rev Esp Cardiol,2009,62(5) :510-519.
8Windhausen F, Hirsch A, Fischer J, et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T[J]. Clin Chem,2009,55(6) :1118-1125.
9Kiyosue A, Hirata Y, Ando J, et al. Plasma eystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J]. Circ J, 2010, 74 (11):2441-2447.
1Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
2Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
3陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
4Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
5Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
6Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
7Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.
8Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation,2007,115:173-179.
6FILLER G,BKENKAMP A,HOFMANN W,et al.Cys C as a marker of GFR-history,indications and future research[J].Clin Biochem,2005,38 (1):1-8.
7BARKA T,VAN DERNOEN H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxigenin-labeled probes geuerated by polymerase chain reaction directly for in situ and northern blot hybridizations[J].J Histochem Cytochem,1993,41 (12):1863-1867.
8SHLIPAK MG,KATZ R,KESTENBAUM B,et al.Clinical and subclinical cardiovascular disease and kidney function decline in the elderly[J].Atherosclerosis,2009,204(1):298-303.
9KILIC T,ONER G,URAL E,et al.Comparison of the long-term prognostic value of cystatin C to other indicators of renal function,markers of inflammation and systolic dysfunction among patients with acute coronary syndrome[J].Atherosclerosis,2009,207(2):552-558.
10GARCA ACUA JM,GONZLEZ-BABARRO E,GRIGORIAN SHAMAGIAN L,et al.Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome[J].Rev Esp Cardiol,2009,62(5):510-519.
